Recure ClinicRecure Clinic
Language / 语言 / Bahasa / Ngôn ngữ
Client LoginWhatsApp
Back to News
Product Deep-Dive

Nerve Recovery 4-in-1 IV: An Academic Breakdown

From the B12 metabolic pathway and the molecular distinction between hydroxocobalamin and methylcobalamin, to the synergistic mechanisms of dexamethasone, B6, and magnesium — an evidence-based, systematic look at the 4-in-1 nerve recovery formula.

Pathway

Vitamin B12 Metabolic Pathway

From dietary intake to intracellular coenzyme activation, B12 passes through seven key steps. Nitrous oxide "oxidizes" B12 at step one, paralyzing the entire pathway.

1

Dietary Intake

B12 bound to animal proteins enters the stomach.

2

Gastric Release

Gastric acid and pepsin free B12; R-binder protects it.

3

Intrinsic Factor Binding

In the duodenum, R-protein degrades and B12 binds parietal-cell-derived Intrinsic Factor (IF).

4

Ileal Absorption

B12-IF complex is endocytosed via cubilin receptor at the terminal ileum.

5

Transcobalamin Transport

Binds Transcobalamin II (TC II) for systemic cellular delivery.

6

Intracellular Activation

Converted intracellularly into Methylcobalamin and Adenosylcobalamin coenzyme forms.

7

Enzyme Catalysis

Methylcobalamin drives methionine synthase; Adenosylcobalamin drives methylmalonyl-CoA mutase.

Methylcobalamin → Methionine Synthase

Catalyzes homocysteine → methionine, supporting DNA methylation and myelin synthesis.

Adenosylcobalamin → Methylmalonyl-CoA Mutase

Catalyzes methylmalonyl-CoA → succinyl-CoA, sustaining myelin fatty acid metabolism.

Molecular Comparison

Hydroxocobalamin vs Methylcobalamin

Both are B12 family, but pharmacokinetics and clinical roles differ markedly. Dual use covers both reservoir and targeting needs.

Hydroxocobalamin
Reservoir
Methylcobalamin
Targeted
Structure
Hydroxyl ligand; requires in-vivo conversion
Methyl ligand; directly active form
Half-Life
Long (hours to days)
Shorter; rapid tissue uptake
Reservoir Role
✓ Long-acting reservoir, slow release
✗ Not a reservoir
Neuro-Targeting
✗ Systemic distribution
✓ Precise nerve-ending targeting
Detox Capacity
✓ Binds cyanide
✗ No cyanide detox
Axon Regrowth
Indirect support
✓ Directly spurs axon regrowth
Other Ingredients

Molecular Mechanisms of Synergistic Ingredients

Dexamethasone

Glucocorticoid

Inhibits phospholipase A2, blocks the arachidonic acid cascade, downregulates pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), and rapidly resolves sterile inflammation and edema around nerves.

Target: Neural Microenvironment

Pyridoxine (Vitamin B6)

Water-Soluble Vitamin

Converted to pyridoxal-5-phosphate (PLP), serving as cofactor for aromatic L-amino acid decarboxylase (AADC) to catalyze synthesis of serotonin, dopamine, and GABA — sustaining neural signal conduction.

Target: Neurotransmitter Synthesis

Magnesium

Intracellular Cation

Blocks NMDA receptor overactivation, prevents calcium overload and excitotoxicity; serves as cofactor for Na⁺/K⁺-ATPase to maintain membrane potential.

Target: Neuroprotection
FAQs

Product FAQs

Hydroxocobalamin provides a long-acting reservoir and systemic baseline supply, while methylcobalamin precisely targets nerve endings and directly drives axon regrowth. They synergize: one sustains and builds infrastructure, the other targets and repairs — covering both systemic and local B12 demands.

Dexamethasone in this therapy is a short-term, low-dose anti-inflammatory intervention used during the acute edema phase — not long-term systemic use. Under doctor evaluation and strict dosing, it is safe.

B12 repairs the myelin sheath and axons (the "hardware"); B6 synthesizes neurotransmitters (the "software/signals"). Without sufficient transmitters, repaired pathways still drop signals — B6 ensures the repaired nerve actually conducts commands.

Magnesium blocks NMDA receptor overactivation, preventing excitotoxic calcium overload, while maintaining membrane potential and microcirculation. It acts as a "circuit breaker," shielding fragile neurons from secondary injury during repair.

Suitable for nitrous-oxide-induced nerve damage, B12-deficiency neuropathy, and peripheral neuropathy with numbness/weakness. Requires doctor evaluation of liver/kidney function and contraindications.

Varies by severity. Mild cases may feel reduced numbness within weeks; moderate-to-severe damage requires months of sustained repair. Best results come with complete cessation of the causative agent (e.g., nitrous oxide).

Nerve Recovery 4-in-1

Evidence-Based Nerve Repair

Doctor-evaluated, personalized formula, full monitoring — RECURE Nerve Recovery 4-in-1 IV.

Enquire via WhatsApp